These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 652588)

  • 1. [Results of HBs and HBc determinations in liver tissue in patients with acute and chronic viral hepatitis].
    Jasiel M; Zielińska W; Zółtowska A
    Pol Tyg Lek; 1978 Mar; 33(10):385-8. PubMed ID: 652588
    [No Abstract]   [Full Text] [Related]  

  • 2. [HBs and HBc antigens in the liver of patients with chronic liver diseases].
    Jabłońska-Kaszewska I; Bielawski W; Zółtowska A; Zamorska I; Fenc E
    Pol Tyg Lek; 1982 Jun; 37(19-20):541-4. PubMed ID: 7177943
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis serological finding "anti-HBc alone", circulating viral DNA and interpretation of findings].
    Gross A; Joller-Jemelka HI; Wicki AN; Grob PJ
    Schweiz Med Wochenschr; 1993 Jun; 123(23):1193-202. PubMed ID: 8327866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core and surface antigens and delta agent in chronic liver disease in Kuwait.
    al Adnani MS
    Histol Histopathol; 1988 Jan; 3(1):57-62. PubMed ID: 2980208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis B virus in women of childbearing age in Mali].
    Maiga YI; Gassin M; Rhaly AA; Pillot J; Marjolet M; Morel D; Dicko K; Dicko I
    Bull Soc Pathol Exot; 1990; 83(1):93-9. PubMed ID: 2350845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological markers of hepatitis in hemodialysis patients and staff.
    Kelly TJ; Hourani MR; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():179-82. PubMed ID: 756042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relevance of immunofluorescence microscopy for diagnosis and prognosis of chronic hepatitis B (author's transl)].
    Drescher M; Ohlen J; Korb G; Selmair H
    Leber Magen Darm; 1981 Jan; 11(1):1-8. PubMed ID: 7012495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB; Torresi J; Lemoh C; Biggs BA
    J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis as sequela of acute viral hepatitis A and hepatitis non A - non B (author's transl)].
    Müller R; Willers H; Freise J; Höpken W
    Z Gastroenterol; 1978 Dec; 16(12):760-7. PubMed ID: 741846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and epidemiological study of 256 cases of acute viral hepatitis].
    Vetencourt Rojas R; Suárez Isea A; Boada Boada JJ; Oropeza F; de Armas J
    G E N; 1984; 38(1-2):1-11. PubMed ID: 6443097
    [No Abstract]   [Full Text] [Related]  

  • 18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic usefulness of anti-HBc-IgM and anti-HD antibodies in acute viral hepatitis.
    Esteban R; Buti M; Jardi R; Hernandez JM; Bacardi R
    Gastroenterol Clin Biol; 1986 Nov; 10(11):748-51. PubMed ID: 3803810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.